Name: Breast Cancer. Risk Assessment, Treatment & New Developments
SKU: 64756417
Price: 106.58 USD
Availability: InStock
Author: Wendell Armstrong

portada Breast Cancer. Risk Assessment, Treatment & New Developments

Breast Cancer. Risk Assessment, Treatment & New Developments

Formato

Libro Físico

Editorial

Nova Science Publishers

Autor

Wendell Armstrong

Año

2016

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.4x1.1 cm

ISBN13

9781634851848

Breast Cancer. Risk Assessment, Treatment & New Developments

Wendell Armstrong (Autor) · Nova Science Publishers · Tapa Blanda

Libro Nuevo Importado

Envío: 15 a 22 días háb.

$ 213.16$ 106.58

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 2 unidades

$ 106.58

Llega entre el 17 Sep y el 30 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Breast Cancer. Risk Assessment, Treatment & New Developments"

Cancer risk prediction models provide an important approach to assess risk and susceptibility by identifying individuals at high risk, facilitating the design and planning of clinical chemoprevention trials, and allowing the evaluation of interventions. Conventional breast cancer risk model includes the cumulative estrogen exposure data such as age, age at menarche and menopause, age at first live birth, and use of HRT in risk calculation, since estrogens are the main risk factor for mammary carcinogenesis. The most widely known and commonly used model for breast cancer risk assessment is the Gail model, which focuses primarily on non-genetic risk factors, with limited information on family history. The first chapter of this book examines breast cancer risk assessment models. The following chapters discuss the association between obesity and breast cancer development; current and future standards for treatment of breast cancer and long term care of patients; and mastectomies and voluntarism.